News

April 10, 2015April 10, 2015

Researchers Discover That the Gut’s Immune System is Involved in Diabetes Development

News

A recent study published in the journal Cell Metabolism revealed that the gut immune system plays an important role in the development of diabetes. The study, which was led by ... Read more

April 8, 2015April 8, 2015

Sedentary Behavior Increases the Risk of Diabetes, Researchers Find

News, Type 2 Diabetes News

A new study recently published in the journal Diabetologia revealed that a sedentary lifestyle is linked to an increased risk of developing diabetes in overweight individuals. The study is entitled ... Read more

April 7, 2015April 7, 2015

Merck Collaborates With ADA To Educate Diabetics About Increased Risk For Pneumococcal Pneumonia And Hepatitis B

News

Merck (MSD) recently announced a partnership with the American Diabetes Association (ADA) that aims to educate adults living with diabetes about their higher risk for serious health issues such as hepatitis B and pneumococcal pneumonia influenza ... Read more

April 6, 2015April 6, 2015

Glyburide Treatment Linked to Adverse Neonatal Outcomes in Pregnant Women with Gestational Diabetes

News

A team of researchers at the University of Maryland, Duke University and the University of North Carolina at Chapel Hill recently published in the journal JAMA Pediatrics findings indicating that the ... Read more

March 31, 2015March 31, 2015

Diabetic Women More Likely to Have Advanced Stage Breast Cancer

News

An article published this week in the new edition of the journal Breast Cancer Research and Treatment examined the impact of diabetes on the stage of breast cancer diagnosis. The ... Read more

March 30, 2015March 30, 2015

New Diabetic Retinopathy Treatment Gets FDA “Breakthrough Therapy” Approval

News, Type 2 Diabetes News

The U.S. Food and Drug Administration on Wednesday, March 25 expanded the approved use for Eylea (aflibercept) injections for treatment of diabetic retinopathy in patients with diabetic macular edema. According ... Read more

March 27, 2015March 27, 2015

Semma Therapeutics Receives $44 Million Funding Led By MPM Capital To Develop Type 1 Diabetes Cell Therapy

News, Type 1 Diabetes News

Cambridge, Massachusetts-based Semma Therapeutics, a biotech company currently developing a cell therapy for Type 1 diabetes, has secured $44 million Series A equity financing and strategic funding. The financing is ... Read more

March 26, 2015March 26, 2015

Expanding Medicaid Under ACA Allowed the Identification of 23% More Individuals With Previously Undiagnosed Diabetes

News, Type 2 Diabetes News

According to a recent study in the journal Diabetes Care, the states that are under the Affordable Care Act (ACA) and have expanded their Medicaid programs are detecting a higher number of ... Read more

March 25, 2015March 25, 2015

US and EU Diabetes Associations Caution Diabetes Community on Insulin Pumps

News

The American Diabetes Association and the European Association for the Study of Diabetes are alerting the community of diabetes patients and the medical community about the lack of information on the ... Read more

March 24, 2015March 24, 2015

Study Reveals That Quantose IR(TM) Measures Insulin Sensitivity Better Than A1C Test For Pre-diabetes

News

Metabolon, Inc. recently announced the results from a study that included samples from ACT NOW, a long-term diabetes prevention assessment of pre-diabetic subjects. Analysis showed that its Quantose IR™ test noted alterations in insulin sensitivity much better than the ... Read more